ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
ARTICLES
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
-
![GettyImages-942955086 lab]( "Sterility Assurance With Louise Ui Fhatharta")
This discussion explores critical aspects of maintaining sterility in pharmaceutical manufacturing, from facility design and environmental monitoring to regulatory compliance and common misconceptions.
-
![GettyImages-1310986619 patient]( "A Thoughtful Copay Program Design That Increased Patient Engagement")
Learn how a partnership with a pharmaceutical company to redesign patient support materials resulted in increased patient engagement and copay program utilization.
-
![GettyImages-1318426446 profile]( "Strategic Management Of The Mature Product Portfolio")
Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.
-
![GettyImages-547131922 research, regulatory, lab]( "Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ")
The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
WHITE PAPERS
-
![GettyImages-891264822 planning, meeting]( "Why An Integrated Approach Ensures Smooth Entry Into The European Market")
Why An Integrated Approach Ensures Smooth Entry Into The European MarketSimplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.
-
![GettyImages-2036497698 clinical lab]( "A CFO's Guide To Driving Growth")
A CFO's Guide To Driving GrowthNavigate the evolving biotech landscape and secure venture capital with insights on strategic partnerships and investor expectations.
-
![GettyImages-1026593952 tablet, data]( "Digital Innovation In Pharmacovigilance")
Digital Innovation In PharmacovigilanceExplore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.
WEBINARS
-
![Cencora - estabished products webinar]( "Unlocking Continued Revenue And Growth From Established Products")
Unlocking Continued Revenue And Growth From Established ProductsGain insights into how pharmaceutical companies successfully handle post-approval regulatory upkeep for established products, focusing on reducing operational costs and expanding global market access.
-
![GettyImages-1368022904 UK]( "Overview Of The UK's International Recognition Procedure")
Overview Of The UK's International Recognition ProcedureGain clarity on the UK's International Recognition Procedure (IRP). Experts Chris Englerth and Graham Donaldson provide key insights into the process and its impact on pharmaceutical product approvals.
-
![GettyImages-2157709105 data, AI]( "Data Governance And AI In Pharma: Overcoming Challenges In DACH Region")
Data Governance And AI In Pharma: Overcoming Challenges In DACH RegionGain insights from industry experts on the implications of the EU's AI Act for data governance professionals, ensuring your organization remains compliant while leveraging AI's transformative potential.
PODCASTS
-
![Digital-marketing-GettyImages-1051659276]( "Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy")
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty PharmacyTune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
![Cencora PharmaLex - PlX talks 30]( "An Overview Of Contamination Control Strategy (CCS)")
An Overview Of Contamination Control Strategy (CCS)Join experts Londa Ritchey and Patrick Nieuwenhuizen as they explore the key role of a contamination control strategy in Annex 1 for ensuring patient safety and continuous manufacturing improvement.
-
![Cencora - PharmaLex Talks 28]( "Early Access Programs: What They Are And How To Plan For Them")
Early Access Programs: What They Are And How To Plan For ThemExplore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
E-BOOKS AND OTHER INSIGHTS
-
![GettyImages-547131922 research, regulatory, lab]( "Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ")
Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQThe FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
-
![iStock-1287080337-lab-microscope-scientist-research.jpg]( "Unraveling The Complexity Of Cell Therapy: Advancements And Challenges")
Unraveling The Complexity Of Cell Therapy: Advancements And ChallengesCell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating The Cell And Gene Regulatory LandscapeNavigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
